For pharmaceutical manufacturers and exporters seeking access to international markets, WHO-GMP certification is one of the most important credentials to obtain. The World Health Organization’s Good Manufacturing Practices standard serves as a globally recognized benchmark for pharmaceutical quality, and it is a prerequisite for participation in international procurement programs and market access in dozens of countries. Understanding what WHO-GMP entails, how to achieve it, and how to maintain it is essential for any serious pharmaceutical exporter.
What Is WHO-GMP?
WHO-GMP refers to the Good Manufacturing Practices guidelines published by the World Health Organization as part of its quality assurance framework for pharmaceutical products. These guidelines define the minimum standards that a pharmaceutical manufacturer must meet to ensure that products are consistently produced and controlled according to quality standards appropriate to their intended use.
The WHO-GMP guidelines cover every aspect of pharmaceutical manufacturing, from the design of premises and equipment to the qualifications of personnel, documentation practices, quality control laboratory operations, and distribution procedures. They are designed to minimize the risks inherent in pharmaceutical production, risks that cannot be eliminated through testing of the final product alone.
WHO-GMP certification is distinct from national GMP requirements, though there is significant overlap. Many national regulatory authorities model their own GMP standards on WHO guidelines, and some countries accept WHO-GMP certification as evidence of compliance with their domestic requirements. This makes WHO-GMP particularly valuable for exporters targeting multiple markets simultaneously.
Why WHO-GMP Matters for Exporters
The practical importance of WHO-GMP certification for pharmaceutical exporters cannot be overstated.
International procurement eligibility is perhaps the most direct benefit. Major international procurement agencies, including UNICEF, the Global Fund to Fight AIDS, Tuberculosis and Malaria, PEPFAR, and various UN agencies, require WHO prequalification or WHO-GMP certification for pharmaceutical products they purchase. These agencies collectively procure billions of dollars in pharmaceutical products annually, and access to this market requires WHO-GMP compliance.
Market access in developing countries is significantly enhanced by WHO-GMP certification. More than 100 countries, particularly in Africa, Southeast Asia, and Latin America, accept WHO-GMP certification as part of their pharmaceutical registration process. For many of these countries, WHO-GMP serves as a proxy for national GMP inspection, simplifying and accelerating market entry.
Competitive differentiation in the global marketplace is another important benefit. WHO-GMP certification signals to buyers, distributors, and regulatory authorities that a manufacturer meets internationally recognized quality standards. In a market where quality concerns can determine purchasing decisions, this certification provides meaningful reassurance.
Foundation for higher certifications is an often-overlooked advantage. The systems and practices required for WHO-GMP compliance form a strong foundation for pursuing US FDA, EU GMP, or other stringent regulatory authority certifications. Companies that have achieved WHO-GMP find the step up to these more demanding certifications more manageable.
Key Requirements for WHO-GMP Certification
WHO-GMP requirements are comprehensive and span multiple areas of pharmaceutical manufacturing operations.
Premises and Facilities
Manufacturing premises must be designed, constructed, and maintained to suit the operations carried out in them. Key requirements include adequate space to prevent contamination and mix-ups, appropriate environmental controls (temperature, humidity, air quality), segregation of manufacturing areas for different product types, dedicated areas for sampling, weighing, and quality control, and proper sanitation and waste management systems.
Equipment
All equipment used in manufacturing, testing, and storage must be designed, installed, and maintained to suit its intended purpose. Equipment must be qualified (IQ, OQ, PQ), calibrated on defined schedules, cleaned according to validated procedures, and maintained with documented maintenance records. Critical equipment must have backup systems or contingency plans to prevent production disruptions.
Documentation
WHO-GMP places heavy emphasis on documentation, often summarized by the principle “if it is not documented, it did not happen.” Required documentation includes master formulae and batch manufacturing records, standard operating procedures (SOPs) for all critical operations, specifications for raw materials, intermediates, and finished products, validation protocols and reports, deviation and change control records, and comprehensive batch documentation enabling full traceability.
Quality Control Laboratories
Quality control (QC) laboratories must be staffed by qualified personnel and equipped with appropriate instrumentation for testing raw materials, in-process samples, and finished products. The QC laboratory must operate independently from production and have the authority to approve or reject materials at any stage. Key requirements include validated analytical methods, reference standards, environmental monitoring, and participation in proficiency testing programs.
Personnel
All personnel involved in manufacturing and quality operations must have appropriate education, training, and experience. WHO-GMP requires a defined organizational structure with clear responsibilities, particularly for key positions including the head of production, head of quality control, and the authorized person responsible for batch release. Ongoing training programs must be documented and regularly updated.
The Certification Process
Achieving WHO-GMP certification involves several steps, and the timeline varies depending on the starting point and the certifying authority.
Self-assessment is the recommended first step. Companies should conduct a thorough gap analysis comparing their current operations against WHO-GMP requirements. This assessment identifies areas requiring improvement before an official inspection.
Remediation and improvement of identified gaps may take several months to several years, depending on the scope. This phase often involves facility upgrades, equipment qualification, documentation system overhauls, personnel training, and process validation.
Application submission is made to the relevant national regulatory authority. In India, this is the Central Drugs Standard Control Organisation (CDSCO) and the respective State Drug Regulatory Authority. The application includes detailed information about the facility, products, and quality systems.
Inspection is conducted by trained inspectors who evaluate the facility against WHO-GMP requirements. The inspection typically takes several days and covers all aspects of operations including premises, equipment, documentation, production processes, quality control, and personnel. Inspectors may review batch records, observe operations in progress, interview personnel, and collect samples.
Report and certification follow the inspection. If the facility meets all requirements, a WHO-GMP certificate is issued. If deficiencies are identified, the company must address them and may need to undergo a re-inspection before certification is granted.
Benefits for Market Access
WHO-GMP certification opens doors to a wide range of markets and procurement channels.
In Sub-Saharan Africa, the majority of national medicines regulatory authorities recognize WHO-GMP certification. Countries such as Nigeria (NAFDAC), Kenya (PPB), Tanzania (TMDA), and Ghana (FDA) all consider WHO-GMP status in their product registration processes.
In Southeast Asia, WHO-GMP certification facilitates market access in countries including Vietnam, Myanmar, Cambodia, and the Philippines. The ASEAN pharmaceutical regulatory harmonization initiative further enhances the value of WHO-GMP certification in this region.
In Latin America, several countries including Peru, Bolivia, Paraguay, and various Central American nations recognize WHO-GMP certification for pharmaceutical imports.
Through international procurement programs, WHO-GMP certified manufacturers can supply products to programs that collectively serve hundreds of millions of patients worldwide.
Maintaining Compliance
Achieving WHO-GMP certification is not a one-time event. Maintaining compliance requires ongoing commitment and investment.
Regular internal audits should be conducted to identify and address potential compliance gaps before they become significant issues. A robust internal audit program covers all areas of WHO-GMP requirements on a defined schedule.
Continuous training ensures that all personnel remain current on GMP requirements and best practices. Training records must be maintained and regularly reviewed.
Management review of the quality management system should occur at defined intervals to assess the continued suitability, adequacy, and effectiveness of quality systems.
Change control procedures must be followed for any changes to processes, equipment, materials, or facilities that could affect product quality. All changes must be evaluated, approved, documented, and verified.
Periodic regulatory inspections will occur as part of the certification renewal process. Being inspection-ready at all times, rather than preparing specifically for inspections, is the hallmark of a mature quality management system.
Key Takeaways
- WHO-GMP certification is a globally recognized standard for pharmaceutical manufacturing quality
- Certification is required for participation in international procurement programs and facilitates market access in over 100 countries
- Key requirements span premises, equipment, documentation, quality control, and personnel
- The certification process involves self-assessment, remediation, application, inspection, and ongoing maintenance
- WHO-GMP provides a strong foundation for pursuing more stringent regulatory certifications
- Maintaining compliance requires ongoing internal audits, training, management review, and change control
At KP Life Science, we work exclusively with WHO-GMP certified manufacturers to ensure that every product we export meets the highest quality standards. Our commitment to quality assurance is not just a business practice; it is a reflection of our responsibility to the patients who ultimately depend on these medicines. We encourage all our manufacturing partners to pursue and maintain WHO-GMP certification as a foundational element of their quality strategy.